Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Lower doses provide sustained pathway support without aggressive intervention
Russo SC (2024)
Comparable rates of adaptive resistance are observed in advanced NSCLC (e.g., more than 60% of initial responders to PD-1/PD-L1 ICIs develop adaptive resistance) and with CTLA-4 inhibition [83,84,85]
It is a subcutaneous injection on a provider-determined schedule
Its legal to purchase from reputable peptide suppliers under a research use agreement
.png?ver=V_XikP92lILtNXWLnvc1tA%3D%3D&tx=w_842)
US$ 20.09
US$ 23.00
US$ 21.70
US$ 29.64
US$ 28.03
US$ 29.79
![Nonane [Standard Material for GC] Environmentally-friendly Oxidation](https://cdn.shopify.com/s/files/1/0029/6648/7113/products/products_037_02fb3e4b-d900-4ea1-ae22-e00e471cd936.jpg?v=1585356982)
